NICE guidance in schizophrenia: How generalisable are drug trials?
Aims and method: To test the National Institute for Clinical Excellence (NICE) assertion that characteristics of participants in the majority of clinical drug trials in schizophrenia do not reflect clinical practice. In particular they were concerned about the relative exclusion of women, older adul...
Κύριος συγγραφέας: | Burns, T |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2006
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Diagnosis and management of endometriosis: summary of NICE guidance
ανά: Kuznetsov, L, κ.ά.
Έκδοση: (2017) -
NICE guidance to working with real-world data
ανά: A. Sh. Motrinchuk, κ.ά.
Έκδοση: (2023-01-01) -
Commentary: Controversies in NICE guidance on chronic kidney disease.
ανά: Landray, M, κ.ά.
Έκδοση: (2008) -
Management of hip fracture in adults: summary of NICE guidance.
ανά: Ftouh, S, κ.ά.
Έκδοση: (2011) -
Commentary: Controversies in NICE guidance on chronic kidney disease
ανά: Landray, M, κ.ά.
Έκδοση: (2008)